COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2531: Articles 25301-25310  | Next

Foundational research and NIH funding enabling Emergency Use Authorization of remdesivir for COVID-19
Cleary, E. G., Jackson, M. J., Folchman-Wagner, Z., Ledley, F. D.
10.1101/2020.07.01.20144576 — Posted: 2020-07-06
Global Assessment of the Relationship between Government Response Measures and COVID-19 Deaths
Hale, T., Hale, A. J., Kira, B., Petherick, A., Phillips, T., Sridhar, D., Thompson, R., Webster, S., Angrist, N.
10.1101/2020.07.04.20145334 — Posted: 2020-07-06 Discussion: Onsite
Global pattern of COVID-19 research
Zhu, X., Jin, Q., Jiang, X., Dan, Y., Zhang, A., Qiu, G., Lou, J., Yu, H.
10.1101/2020.07.04.20146530 — Posted: 2020-07-06 Discussion: Onsite
Computational fluid dynamic (CFD), air flow-droplet dispersion, and indoor CO2 analysis for healthy public space configuration to complywith COVID 19 protocol
Adwibowo, A.
10.1101/2020.07.02.20145219 — Posted: 2020-07-06
Who is dying from Covid-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
Salmon, R. L., Monaghan, S. P.
10.1101/2020.07.01.20136317 — Posted: 2020-07-06
A County-Level Susceptibility Index and Coronavirus Disease 2019 Mortality in the United States: A Socioecological Study
Khan, S., McCabe, M., Krefman, A., Petito, L. C., Yang, X., Kershaw, K., Pool, L., Allen, N. B.
10.1101/2020.07.04.20146084 — Posted: 2020-07-06
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)
Gruber, C., Patel, R., Trachman, R., Lepow, L., Amanat, F., Krammer, F., Wilson, K. M., Onel, K., Geanon, D., Tuballes, K., Patel, M., Mouskas, K., Simons, N., Barcessat, V., Del Valle, D., Udondem, S., Kang, G., Gangadharan, S., Ofori-Amanfo, G., Rahman, A., Kim-Schulze, S., Charney, A., Gnjatic, S., Gelb, B., Merad, M., Bogunovic, D.
10.1101/2020.07.04.20142752 — Posted: 2020-07-06 Discussion: Onsite | Offsite
Has the Indian lockdown averted deaths?
Raju, S.
10.1101/2020.06.27.20134932 — Posted: 2020-07-06
Dual-Histamine Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients
Hogan, R. B., Hogan, R. B., Cannon, T., Rappi, M., Studdard, J., Paul, D., Dooley, T. P.
10.1101/2020.06.30.20137752 — Posted: 2020-07-06 Discussion: Onsite
Daily viral kinetics and innate and adaptive immune responses assessment in COVID-19: a case series
Vetter, P., Eberhardt, C., Meyer, B., Martinez, P., Torriani, G., Pigny, F., Lemeille, S., Cordey, S., Laubscher, F., Vu, D.-L., Calame, A., Schibler, M., Jacquerioz, F., Blanchard, G., Siegrist, C.-A., Kaiser, L., Didierlaurent, A., eckerle, i.
10.1101/2020.07.02.20143271 — Posted: 2020-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).